Canada markets closed

Radient Technologies Inc. (RTI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1100+0.0050 (+4.76%)
At close: 3:46PM EST
Full screen
Previous Close0.1050
Open0.1050
Bid0.1100 x N/A
Ask0.1150 x N/A
Day's Range0.1000 - 0.1150
52 Week Range0.0750 - 0.5900
Volume580,059
Avg. Volume353,006
Market Cap35.244M
Beta (5Y Monthly)1.99
PE Ratio (TTM)N/A
EPS (TTM)-0.1310
Earnings DateDec. 04, 2020 - Dec. 08, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Radient Technologies Inc. Announces Second Quarter 2021 Financial Results and Provides a Corporate Update
    Newsfile

    Radient Technologies Inc. Announces Second Quarter 2021 Financial Results and Provides a Corporate Update

    Edmonton, Alberta--(Newsfile Corp. - November 30, 2020) - Radient Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF) ("Radient" or the "Company"), a manufacturer of high quality cannabinoids based formulations and products today announced its results for the second quarter ended September 30, 2020 and provided an update on its recent corporate developments."The second quarter was a period of transition, coming from the previous quarter where production had been dramatically scaled back, and ramping back up ...

  • Radient Technologies Announces Receipt of Cannabis Research Licence for Human Administration Trials and Sensory and Taste Evaluation of Cannabis Products
    Newsfile

    Radient Technologies Announces Receipt of Cannabis Research Licence for Human Administration Trials and Sensory and Taste Evaluation of Cannabis Products

    Edmonton, Alberta--(Newsfile Corp. - November 27, 2020) - Radient Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF) ("Radient" or the "Company"), is pleased to announce that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannabis Regulations. This license permits Radient to expand its research activities by allowing the controlled administration of cannabis to human subjects to complete a comprehensive evaluation of sensory preferences.A human sensory panel is an extremely valuable tool ...

  • Radient Technologies Announces partnership with US based Dreamy CBD
    GlobeNewswire

    Radient Technologies Announces partnership with US based Dreamy CBD

    * Radient launches foray into the CBD market through exclusive rights to Dreamy CBD brands EDMONTON, Alberta, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), is pleased to announce a licensing agreement with Dreamy Co., (“Dreamy”) to bring in Dreamy CBD products under Radient’s platform to Canada and extend it to other international markets. Initially founded in the US, Dreamy has developed a lifestyle brand over the past decade focused on the Health and Wellness space before branching into the CBD vertical. Dreamy is focused on creating and inspiring people to use plant medicine and holistic healing in place of conventional pharmaceutical solutions. In the US, Dreamy CBD enjoys a strong presence in California, and the Dreamy brand has a strong association with a positive lifestyle in the rapidly growing Wellness space. The Dreamy CBD products comprise CBD tinctures, CBD distillates, CBD edibles, CBD cosmetics, and CBD Vape Cartridges geared towards the recreational and medical cannabis market.Under this partnership, Radient will have exclusive rights to the licenses and trademarks for Dreamy CBD brands and will collaborate jointly with Dreamy to produce their CBD products and launch their brands in Canada. Radient will be involved in providing the processing facilities in Edmonton and the necessary infrastructure to extract CBD products for Dreamy CBD. In addition, through its Sales License and associated registrations in the provinces, Radient will look to build the Dreamy CBD product portfolio in Canada. On the international front, Radient will produce their CBD based products for markets in Thailand and Japan that are witnessing a strong surge in CBD products consumption, especially in the Wellness space. This will be after completing a comprehensive review of the trade requirements with local partners in these jurisdictions. The partnership is being set initially for a two-year term with an annual renewable option, with Radient reserving the right of first refusal to acquire Dreamy.About Radient Radient Technologies is an innovative science-based company that is a commercial manufacturer of high quality cannabinoid based formulations, ingredients and products. Utilizing a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant, Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Radient also has a science lab that is focused on innovation with expertise in formulations and technologies offering unique solutions in the cannabis and wellness space. Please visit www.radientinc.com for more information.SOURCE: Radient Technologies Inc.For further information please contact:Radient - Investor Relations, ir@radientinc.comForward Looking Information: This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the growth of the Company’s business operations. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.